#None #healthcare #MarketsandMarkets #Infection Control

The Expanding European Infection Control Market

The European infection control market is experiencing significant growth, with projections indicating it will reach $20.58 billion by 2030. This growth represents a robust compound annual growth rate (CAGR) of 6.6% from 2025 to 2030, following a market valuation of $14.14 billion in 2024 and $14.99 billion in 2025. The surge in this sector can be attributed to several factors, including the increasing prevalence of healthcare-associated infections (HAIs), a rise in surgical procedures, advancements in reprocessing technology, and an enhanced focus on sterilization and disinfection within the food industry.

Factors Driving Growth

1. Prevalence of Healthcare-Associated Infections

The increase in HAIs is a major driver for the infection control market. With more surgeries being performed and the complexity of procedures growing, the demand for effective infection control solutions has never been higher.

2. Surgical Procedures on the Rise

As the number of surgical operations rises, particularly in the context of increasingly sophisticated medical interventions, the need for efficient sterilization and infection control measures becomes more pressing.

3. Technological Advancements

Ongoing advancements in sterilization technology are also playing a crucial role in market growth. Improved methods and equipment allow healthcare facilities to maintain high standards of hygiene and reduce the risk of infections.

4. Focus on Food Industry

In addition to the healthcare sector, there is an increasing emphasis on sterilization and disinfection in the food industry, responding to rising consumer expectations for food safety and hygiene standards.

Market Segmentation

The European infection control market can be segmented based on sterilization products and services. The sterilization equipment segment, which includes sterilization technologies and products, commanded the most significant share of the market in 2024. This segment's growth is supported by the rising number of surgical procedures and stringent regulatory standards that govern infection control practices.

End Users

The infection control market is further segmented by its end users, which include hospitals and clinics, medical device firms, pharmaceutical companies, and life sciences organizations. In 2024, hospitals and clinics held the largest market share, driven by the increasing rates of HAIs and the growth of healthcare facility establishments.

Geographic Analysis

Geographically, the market is divided among 13 countries, including Germany, the UK, France, and Italy, among others. Germany leads this market due to its advanced healthcare infrastructure and a high volume of surgical admissions.

Key Players in the Market

Several prominent players have established themselves in the European infection control sector. Companies such as STERIS plc, Getinge AB, and Ecolab, Inc. are at the forefront, constantly innovating to meet the growing demands of infection control. For example:

• - STERIS plc has strengthened its position by acquiring assets from Becton, Dickinson, which enhances their offerings in sterile processing.
• - Reckitt Benckiser has focused on expanding its brand's presence in the institutional hygiene market by introducing product ranges specifically for healthcare settings.
• - Paul Hartmann AG is known for its Mission Infection Prevention initiative, which collaborates with global health organizations to enhance infection prevention efforts.

Conclusion

In summary, the burgeoning European infection control market is on a firm growth trajectory, driven by increased awareness of healthcare-associated infections, advancements in technology, and rigorous regulatory standards. As we look towards 2030, this market is poised to become an essential component of not just healthcare but also sectors like food safety, showcasing its wider impact on public health and safety.